Texas A&M Researchers Detail Groundbreaking Angelman Syndrome Development
March 23, 2023
March 23, 2023
COLLEGE STATION, Texas, March 23 (TNSjou) -- Texas A&M University's College of Veterinary Medicine and Biomedical Sciences issued the following news release on March 22, 2023:
* * *
A new publication explains the novel science behind the first molecular therapeutic for the rare neurogenetic disorder to advance into clinical development.
* * *
Researchers at Texas A&M University have developed the first molecular therapeutic for Angelman . . .
* * *
A new publication explains the novel science behind the first molecular therapeutic for the rare neurogenetic disorder to advance into clinical development.
* * *
Researchers at Texas A&M University have developed the first molecular therapeutic for Angelman . . .